伴随性疾病在肌缩侧面硬化症的患病率和影响
1Institute of Clinical Neurobiology, Alberichgasse 5/13, Vienna, A-1150, Austria. kurt.jellinger@univie.ac.at.
Journal of neural transmission (Vienna, Austria : 1996)
|June 14, 2025
概括
肌缩侧面硬化症 (ALS) 伴随疾病,如糖尿病和心血管问题影响疾病的进展. 了解这些联系对于更好的ALS诊断和治疗策略至关重要.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种复杂的神经退行性疾病,原因不明,进展变化.
- 伴随性疾病在ALS易感性和疾病进展中的作用尚未完全理解.
- 在ALS患者中,多病症是常见的,因此需要对相关疾病进行研究.
研究的目的:
- 使用医疗数据库调查与肌缩侧面硬化症 (ALS) 相关的疾病.
- 确定这些并发症对ALS发病和进展的影响.
- 在疾病修饰性并发症中识别潜在的治疗点.
主要方法:
- 分析医疗数据库以确定与ALS相关的并发症.
- 对各种疾病对ALS发病率和进展的影响的统计评估.
- 关于ALS和并发性疾病之间的相互作用现有文献的综述.
主要成果:
- 糖尿病,脱脂症和心血管并发症与ALS风险和预后有关.
- 低代谢性疾病和某些心血管疾病可能会提供对ALS发病率的保护.
- 冠心病和高血压对ALS疾病的进展产生负面影响.
结论:
- 伴随性疾病显著影响肌缩侧面硬化症 (ALS) 的发病,进展和预后.
- 识别和管理并发症可能会导致改善ALS的诊断工具和治疗方法.
- 异质性ALS表明遗传,病原体和环境因素之间的复杂相互作用,包括并发症.
相关概念视频
Parkinson's Disease: Overview
500
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
COPD: Pathogenesis and Clinical Features
246
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
246
Factors Affecting Illness
4.2K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.2K
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K


